Related Experiment Video
Updated: Sep 17, 2025
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Benign multicystic peritoneal mesothelioma: use of hyperthermic intraperitoneal chemotherapy (HIPEC)
Silvia Sánchez Infantes1, César Lévano-Linares2, Tamara Diaz Vico3
1Cirugía General y del Aparato Digestivo, Hospital Universitario Rey Juan Carlos, Mostoles.
Abstract:
Benign Multicystic Peritoneal Mesothelioma (BMPM) is a rare mesothelial neoplasm, first described in 1979, with an estimated incidence of 1-2 cases per million. It primarily affects women of reproductive age and has been associated with chronic inflammatory processes such as endometriosis or previous surgeries. Due to its clinical and radiological similarity to ovarian neoplasms, it is essential to include gynecological pathology in the differential diagnosis.
Insights
Benign Multicystic Peritoneal Mesothelioma (BMPM) is a rare tumor affecting women of reproductive age. Gynecological pathology must be considered in its differential diagnosis due to similar presentations.
Area of Science:
- Oncology
- Gynecopathology
Background:
- Benign Multicystic Peritoneal Mesothelioma (BMPM) is a rare mesothelial neoplasm.
- First described in 1979, BMPM has an incidence of 1-2 cases per million.
- It predominantly affects women of reproductive age.
